Home > > > > > Report Detail

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2020-2025

Publisher Name :
Date: 24-Feb-2020
No. of pages: 118

According to this study, over the next five years the Irritable Bowel Syndrome (IBS) market will register a 16.6% CAGR in terms of revenue, the global market size will reach $ 6505.6 million by 2025, from $ 3519.9 million in 2019. In particular, this report presents the global revenue market share of key companies in Irritable Bowel Syndrome (IBS) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Irritable Bowel Syndrome (IBS) market by type, application, key companies and key regions.

This study considers the Irritable Bowel Syndrome (IBS) value generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

- IBS-D Drug

- IBS-C Drug

- Other

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

- Women

- Men

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Allergan

- Bausch Health

- Sucampo Pharmaceuticals

- McNeil Consumer Healthcare

- Takeda

- IM HealthScience

- Sebela Pharmaceuticals

- Astellas Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Irritable Bowel Syndrome (IBS) market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Irritable Bowel Syndrome (IBS) market by identifying its various subsegments.

- Focuses on the key global Irritable Bowel Syndrome (IBS) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Irritable Bowel Syndrome (IBS) with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Irritable Bowel Syndrome (IBS) submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2020-2025

Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Market Size 2015-2025
2.1.2 Irritable Bowel Syndrome (IBS) Market Size CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-D Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Market Size by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
2.3.2 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (2015-2020)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Market Size by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
2.5.2 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Application (2015-2020)

3 Global Irritable Bowel Syndrome (IBS) by Players
3.1 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Market Size by Players (2018-2020)
3.1.2 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Players (2018-2020)
3.2 Global Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Irritable Bowel Syndrome (IBS) by Regions
4.1 Irritable Bowel Syndrome (IBS) Market Size by Regions
4.2 Americas Irritable Bowel Syndrome (IBS) Market Size Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Market Size Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Market Size Growth
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth

5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Market Size by Countries
5.2 Americas Irritable Bowel Syndrome (IBS) Market Size by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Market Size by Regions
6.2 APAC Irritable Bowel Syndrome (IBS) Market Size by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Countries
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Irritable Bowel Syndrome (IBS) Market Forecast
10.1 Global Irritable Bowel Syndrome (IBS) Market Size Forecast (2021-2025)
10.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
10.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
10.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application

11 Key Players Analysis
11.1 Allergan
11.1.1 Company Details
11.1.2 Irritable Bowel Syndrome (IBS) Product Offered
11.1.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Allergan News
11.2 Bausch Health
11.2.1 Company Details
11.2.2 Irritable Bowel Syndrome (IBS) Product Offered
11.2.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Bausch Health News
11.3 Sucampo Pharmaceuticals
11.3.1 Company Details
11.3.2 Irritable Bowel Syndrome (IBS) Product Offered
11.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Sucampo Pharmaceuticals News
11.4 McNeil Consumer Healthcare
11.4.1 Company Details
11.4.2 Irritable Bowel Syndrome (IBS) Product Offered
11.4.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 McNeil Consumer Healthcare News
11.5 Takeda
11.5.1 Company Details
11.5.2 Irritable Bowel Syndrome (IBS) Product Offered
11.5.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Takeda News
11.6 IM HealthScience
11.6.1 Company Details
11.6.2 Irritable Bowel Syndrome (IBS) Product Offered
11.6.3 IM HealthScience Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 IM HealthScience News
11.7 Sebela Pharmaceuticals
11.7.1 Company Details
11.7.2 Irritable Bowel Syndrome (IBS) Product Offered
11.7.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Sebela Pharmaceuticals News
11.8 Astellas Pharmaceuticals
11.8.1 Company Details
11.8.2 Irritable Bowel Syndrome (IBS) Product Offered
11.8.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Astellas Pharmaceuticals News

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Irritable Bowel Syndrome (IBS) Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of IBS-D Drug
Table 5. Major Players of IBS-C Drug
Table 6. Major Players of Other
Table 7. Irritable Bowel Syndrome (IBS) Market Size by Type (2014-2019) ($ Millions)
Table 8. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 9. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 10. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 11. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2018-2020) ($ Millions)
Table 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2018-2020)
Table 13. Global Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
Table 14. Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Irritable Bowel Syndrome (IBS) Market Size by Regions 2015-2020 ($ Millions)
Table 18. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions 2015-2020
Table 19. Americas Irritable Bowel Syndrome (IBS) Market Size by Countries (2015-2020) ($ Millions)
Table 20. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries (2015-2020)
Table 21. Americas Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) ($ Millions)
Table 22. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 23. Americas Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 24. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 25. APAC Irritable Bowel Syndrome (IBS) Market Size by Regions (2015-2020) ($ Millions)
Table 26. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions (2015-2020)
Table 27. APAC Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) ($ Millions)
Table 28. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 29. APAC Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 30. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 31. Europe Irritable Bowel Syndrome (IBS) Market Size by Countries (2015-2020) ($ Millions)
Table 32. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries (2015-2020)
Table 33. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) ($ Millions)
Table 34. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 35. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 36. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 37. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Countries (2015-2020) ($ Millions)
Table 38. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries (2015-2020)
Table 39. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) ($ Millions)
Table 40. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Table 41. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) ($ Millions)
Table 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2015-2020)
Table 43. Key and Potential Regions of Irritable Bowel Syndrome (IBS)
Table 44. Key Application and Potential Industries of Irritable Bowel Syndrome (IBS)
Table 45. Key Challenges of Irritable Bowel Syndrome (IBS)
Table 46. Key Trends of Irritable Bowel Syndrome (IBS)
Table 47. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 48. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Regions
Table 49. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Type (2021-2025) ($ Millions)
Table 50. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Type (2021-2025)
Table 51. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Application (2021-2025) ($ Millions)
Table 52. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Application (2021-2025)
Table 53. Allergan Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 54. Allergan Irritable Bowel Syndrome (IBS) Product Offered
Table 55. Allergan Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 56. Allergan Main Business
Table 57. Allergan Latest Developments
Table 58. Bausch Health Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 59. Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
Table 60. Bausch Health Main Business
Table 61. Bausch Health Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 62. Bausch Health Latest Developments
Table 63. Sucampo Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 64. Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 65. Sucampo Pharmaceuticals Main Business
Table 66. Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 67. Sucampo Pharmaceuticals Latest Developments
Table 68. McNeil Consumer Healthcare Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 69. McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Product Offered
Table 70. McNeil Consumer Healthcare Main Business
Table 71. McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 72. McNeil Consumer Healthcare Latest Developments
Table 73. Takeda Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 74. Takeda Irritable Bowel Syndrome (IBS) Product Offered
Table 75. Takeda Main Business
Table 76. Takeda Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 77. Takeda Latest Developments
Table 78. IM HealthScience Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 79. IM HealthScience Irritable Bowel Syndrome (IBS) Product Offered
Table 80. IM HealthScience Main Business
Table 81. IM HealthScience Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 82. IM HealthScience Latest Developments
Table 83. Sebela Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 84. Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 85. Sebela Pharmaceuticals Main Business
Table 86. Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 87. Sebela Pharmaceuticals Latest Developments
Table 88. Astellas Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Irritable Bowel Syndrome (IBS) Major Market Areas and Its Competitors
Table 89. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 90. Astellas Pharmaceuticals Main Business
Table 91. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue and Gross Margin (2018-2020E)
Table 92. Astellas Pharmaceuticals Latest Developments
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2015-2020)
Figure 5. Global IBS-D Drug Market Size Growth Rate
Figure 6. Global IBS-C Drug Market Size Growth Rate
Figure 7. Global Other Market Size Growth Rate
Figure 8. Irritable Bowel Syndrome (IBS) in Women
Figure 9. Global Irritable Bowel Syndrome (IBS) Market: Women (2015-2020) ($ Millions)
Figure 10. Irritable Bowel Syndrome (IBS) in Men
Figure 11. Global Irritable Bowel Syndrome (IBS) Market: Men (2015-2020) ($ Millions)
Figure 12. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 13. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions 2015-2020
Figure 14. Americas Irritable Bowel Syndrome (IBS) Market Size 2015-2020 ($ Millions)
Figure 15. APAC Irritable Bowel Syndrome (IBS) Market Size 2015-2020 ($ Millions)
Figure 16. Europe Irritable Bowel Syndrome (IBS) Market Size 2015-2020 ($ Millions)
Figure 17. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2015-2020 ($ Millions)
Figure 18. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries in 2019
Figure 19. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2019
Figure 20. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 21. United States Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 22. Canada Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 23. Mexico Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 24. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Regions in 2019
Figure 25. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2019
Figure 26. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 27. China Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 28. Japan Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 29. Korea Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 30. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 31. India Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 32. Australia Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 33. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries in 2019
Figure 34. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2019
Figure 35. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 36. Germany Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 37. France Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 38. UK Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 39. Italy Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 40. Russia Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 41. Spain Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Countries in 2019
Figure 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2019
Figure 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2019
Figure 45. Egypt Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 46. South Africa Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 47. Israel Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 48. Turkey Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 49. GCC Countries Irritable Bowel Syndrome (IBS) Market Size Growth 2015-2020 ($ Millions)
Figure 50. Global Irritable Bowel Syndrome (IBS) arket Size Forecast (2021-2025) ($ Millions)
Figure 51. Americas Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 52. APAC Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 53. Europe Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 54. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 55. United States Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 56. Canada Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 57. Mexico Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 58. Brazil Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 59. China Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 60. Japan Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 61. Korea Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 62. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 63. India Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 64. Australia Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 65. Germany Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 66. France Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 67. UK Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 68. Italy Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 69. Russia Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 70. Spain Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 71. Egypt Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 72. South Africa Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 73. Israel Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 74. Turkey Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
Figure 75. GCC Countries Irritable Bowel Syndrome (IBS) Market Size 2021-2025 ($ Millions)
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs